One million haemopoietic stem-cell transplants: a retrospective observational study

Warwick, 2013, Globally consistent coding systems for medical products of human origin, Bull World Health Organ, 91, 314, 10.2471/BLT.12.116988

Linden, 2009, History of solid organ transplantation and organ donation, Crit Care Clin, 25, 165, 10.1016/j.ccc.2008.12.001

Sleeboom-Faulkner, 2013, Experimental treatments: regulating stem-cell therapies worldwide, Nature, 495, 47, 10.1038/495047b

Efrat, 2013, The politics of combating the organ trade: lessons from the Israeli and Pakistani experience, Am J Transplant, 13, 1650, 10.1111/ajt.12254

2010, WHO guiding principles on human cell, tissue and organ transplantation, Transplantation, 90, 229, 10.1097/TP.0b013e3181ec29f0

Aljurf, 2014, Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts, Bone Marrow Transplant, 49, 1016, 10.1038/bmt.2014.78

Epstein, 2012, Best practices in regulation of blood and blood products, Biologicals, 40, 200, 10.1016/j.biologicals.2011.11.002

Stafinski, 2010, Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems, Pharmacoeconomics, 28, 113, 10.2165/11530820-000000000-00000

Tunis, 2006, Coverage options for promising technologies: Medicare's ‘coverage with evidence development’, Health Aff (Millwood), 25, 1218, 10.1377/hlthaff.25.5.1218

Copelan, 2006, Hematopoietic stem-cell transplantation, N Engl J Med, 354, 1813, 10.1056/NEJMra052638

Ljungman, 2010, Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009, Bone Marrow Transplant, 45, 219, 10.1038/bmt.2009.141

Pasquini, 2010, 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders, Clin Transpl, 2010, 87

Higgs, 2008, A new dawn for stem-cell therapy, N Engl J Med, 358, 964, 10.1056/NEJMcibr0708823

Martin, 2014, The survey on cellular and engineered tissue therapies in Europe in 2011, Tissue Eng Part A, 20, 842

Hirt, 2014, Cardiac tissue engineering: state of the art, Circ Res, 114, 354, 10.1161/CIRCRESAHA.114.300522

Fulco, 2014, Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial, Lancet, 384, 337, 10.1016/S0140-6736(14)60544-4

Osgood, 1939, Aplastic anemia treated with daily transfusions and intravenous marrow; a case report, Ann Intern Med, 13, 357, 10.7326/0003-4819-13-2-357

Thomas, 1957, Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy, N Engl J Med, 257, 491, 10.1056/NEJM195709122571102

Bortin, 1970, A compendium of reported human bone marrow transplants, Transplantation, 9, 571, 10.1097/00007890-197006000-00006

Passweg, 2012, The EBMT activity survey: 1990-2010, Bone Marrow Transplant, 47, 906, 10.1038/bmt.2012.66

Hurley, 2010, Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products, Bone Marrow Transplant, 45, 819, 10.1038/bmt.2010.8

Gratwohl, 2010, Hematopoietic stem cell transplantation: a global perspective, JAMA, 303, 1617, 10.1001/jama.2010.491

Thomas, 1975, Bone-marrow transplantation (second of two parts), N Engl J Med, 292, 895, 10.1056/NEJM197504242921706

Cheson, 1989, Autologous bone marrow transplantation. Current status and future directions, Ann Intern Med, 110, 51, 10.7326/0003-4819-110-1-51

Schulman, 2003, Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer, Bone Marrow Transplant, 31, 205, 10.1038/sj.bmt.1703795

Vogl, 2006, High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed, Bone Marrow Transplant, 37, 985, 10.1038/sj.bmt.1705366

Thomas, 1979, Marrow transplantation for acute nonlymphoblastic leukemia in first remission, N Engl J Med, 301, 597, 10.1056/NEJM197909133011109

Thomas, 1978, Marrow transplantation for nonmalignant disorders, N Engl J Med, 298, 963, 10.1056/NEJM197804272981709

Bortin, 1987, Bone marrow transplantation in leukemia using family donors other than HLA-identical siblings: a preliminary report from the International Bone Marrow Transplant Registry, Transplant Proc, 19, 2629

Gooley, 2010, Reduced mortality after allogeneic hematopoietic-cell transplantation, N Engl J Med, 363, 2091, 10.1056/NEJMoa1004383

Petersdorf, 2001, Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation, N Engl J Med, 345, 1794, 10.1056/NEJMoa011826

Gluckman, 1989, Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling, N Engl J Med, 321, 1174, 10.1056/NEJM198910263211707

Oudshoorn, 1994, Bone Marrow Donors Worldwide: a successful exercise in international cooperation, Bone Marrow Transplant, 14, 3

Gratwohl, 2013, Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study, Haematologica, 98, 1282, 10.3324/haematol.2012.076349

Butler, 1996, US company comes under fire over patent on umbilical cord cells, Nature, 382, 99, 10.1038/382099a0

Gratwohl, 2014, Use of the quality management system “JACIE” and outcome after hematopoietic stem cell transplantation, Haematologica, 99, 908, 10.3324/haematol.2013.096461

Lombardini, 2013, Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy, Vox Sang, 105, 174, 10.1111/vox.12026

Boo, 2011, Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association, Blood, 117, 21, 10.1182/blood-2010-07-298430

Goldman, 1994, A special report: bone marrow transplants using volunteer donors–recommendations and requirements for a standardized practice throughout the world–1994 update. The WMDA Executive Committee, Blood, 84, 2833, 10.1182/blood.V84.9.2833.2833

Gratwohl, 2010, Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology, Haematologica, 95, 637, 10.3324/haematol.2009.015586

Frassoni, 2000, Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia, Lancet, 355, 1393, 10.1016/S0140-6736(00)02137-1

Sorror, 2009, Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes, Biol Blood Marrow Transplant, 15, 149, 10.1016/j.bbmt.2008.12.498

Gratwohl, 2012, The EBMT risk score, Bone Marrow Transplant, 47, 749, 10.1038/bmt.2011.110

Cornelissen, 2012, The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach, Nat Rev Clin Oncol, 9, 579, 10.1038/nrclinonc.2012.150

Gratwohl, 2012, Organ donation: stricter management of organ transplants, Nature, 488, 459, 10.1038/488459b